The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

May 2010

Volume 6 Number 1

Clinical research

First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent
Ormiston J, Lefèvre T, Grube E, Allocco D, Dawkins K
May 25, 2010
Mitral annular reduction with subablative therapeutic ultrasound: pre-clinical evaluation of the ReCor device
Jilaihawi H, Virmani R, Nakagawa H, Ducharme A, Shi Y-F, Carter-Monroe N, Ladich E, Iyer M, Ikeda A, Asgar A, Bonan R
May 25, 2010
Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial
Moschovitis A, Simon R, Seidenstücker A, Klauss V, Baylacher M, RN R, Lüscher T, Moccetti T, Windecker S, Meier B, Hess O
May 25, 2010
Optical coherence tomography (OCT) strut-level analysis of drug-eluting stents (DES) in human coronary bifurcations
Kyono H, Guagliumi G, Sirbu V, Rosenthal N, Tahara S, Musumeci G, Trivisonno A, Bezerra H, Costa M
May 25, 2010
Optical coherence tomography for the assessment of pericardium covered stents for the treatment of degenerated saphenous vein grafts
Tyczynski P, Kukreja N, van Geuns R, Wykrzykowska J, Sheppard M, Di Mario C
May 25, 2010
Strut apposition after coronary stent implantation visualised with optical coherence tomography
Radu M, Jørgensen E, Kelbæk H, Helqvist S, Skovgaard L, Saunamäki K
May 25, 2010
Optical coherence tomography in unprotected left main coronary artery stenting
Parodi G, Maehara A, Giuliani G, Kubo T, Mintz G, Migliorini A, Valenti R, Carrabba N, Antoniucci D
May 25, 2010
Acute left main obstructions following TAVI
Stabile E, Sorropago G, Cioppa A, Cota L, Agrusta M, Lucchetti V, Rubino P
May 25, 2010
Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction
de Boer M, Hoorntje J, Gosselink A, Suryapranata H, van’t Hof A
May 25, 2010
A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated By EveroLimus-Eluting Stent) trial
Moreno R, Garcia E, Teles R, Almeida M, Carvalho H, Sabaté M, Martin-Reyes R, Rumoroso J-R, Galeote G, Goicolea F, Moreu J, Mainar V, Mauri J, Ferreira R, Valdes M, Perez de Prado A, Martin-Yuste V, Jiménez-Valero S, Sanchez Recalde A, Calvo L, de Sa E, Macaya C, López-Sendón J-L
May 25, 2010

Experimental research

Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimus and tacrolimus-eluting stents
van Beusekom H, Sorop O, van den Heuvel M, Onuma Y, Duncker D, Danser A, van der Giessen WJ
May 25, 2010
Polymer-free cerivastatin-eluting stent shows superior neointimal inhibition with preserved vasomotor function compared to polymer-based paclitaxel-eluting stent in rabbit iliac arteries
Pendyala L, Yin X, Li J, Shinke T, Xu Y, Chen J, King III S, Colley K, Goodchild T, Chronos N, Hou D
May 25, 2010
A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan
Segev A, Nili N, Osherov A, Qiang B, Wong A, Pillarisetti S, Strauss B
May 25, 2010
Micro-computed tomographic assessment following extremely oversized partial postdilatation of drug-eluting stents
Basalus M, van Houwelingen K, Ankone M, Feijen J, von Birgelen C
May 25, 2010

EuroIntervention Tools & Techniques

Coronary guidewires
Erglis A
May 25, 2010
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke